Researchers are leveraging artificial intelligence to develop digital models and conduct virtual clinical trials, aiming to improve treatment outcomes for children with brain tumors. This innovative approach addresses the unique challenges of pediatric brain cancer, offering hope for more effective and personalized therapies while overcoming the limitations of traditional clinical trials.